Quetzal Therapeutics: QTX-2101 Expanded Access Policy

Quetzal Therapeutics is a clinical-stage biotechnology company pioneering medicines for hematologic malignancies and rare diseases. Our mission is to deliver transformative therapies to patients as swiftly and safely as possible.

Currently, access to our investigational therapy, QTX-2101, is only available through participation in a clinical trial. We believe this is the most appropriate and scientifically rigorous way to evaluate safety and efficacy.

Quetzal Therapeutics does not currently offer Expanded Access. In the future, we may consider Expanded Access programs if appropriate and feasible. If such programs become available, requests must come directly from the patient’s treating physician and will be evaluated on a case-by-case basis.

How to Submit a Request

If you have questions or would like to inquire about potential future Expanded Access opportunities, please email:
[email protected]

Submission of an inquiry or request does not guarantee Expanded Access, if offered.